Zhejiang Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2,899	1,966	1,460	1,438	1,769	1,629
Short-Term Investments	-	-	-	-	2.9	50
Trading Asset Securities	288.33	294.91	328.31	447.29	454.4	270.73
Cash & Short-Term Investments	3,188	2,261	1,788	1,885	2,226	1,950
Cash Growth	62.31%	26.41%	-5.15%	-15.30%	14.17%	10.91%
Accounts Receivable	1,729	1,830	1,419	1,501	1,594	1,402
Other Receivables	70.61	194.79	239.14	67.35	105.17	141.38
Receivables	1,800	2,025	1,658	1,568	1,699	1,544
Inventory	1,981	2,133	2,011	1,995	1,873	1,480
Prepaid Expenses	-	-	-	0.03	0.36	0.9
Other Current Assets	152.8	166.46	143.88	207.17	236.04	143.85
Total Current Assets	7,121	6,585	5,601	5,655	6,035	5,118
Property, Plant & Equipment	5,976	6,121	6,019	5,618	5,360	4,513
Long-Term Investments	146.99	156.51	166.21	144.51	126.07	195.48
Goodwill	-	-	18.68	27.91	36.03	-
Other Intangible Assets	623.64	684.4	744.3	747.68	728.81	409.75
Long-Term Deferred Tax Assets	137.58	124.94	82.12	77.41	78.8	86.49
Long-Term Deferred Charges	9.51	12.81	6.22	8.85	0.41	27.18
Other Long-Term Assets	120.79	110.66	141.15	153.27	167.76	150.18
Total Assets	14,136	13,795	12,780	12,433	12,532	10,500
Accounts Payable	1,052	744.68	744.03	702.48	897.83	504.75
Accrued Expenses	152.47	544.93	534.16	263.98	287.32	534.42
Short-Term Debt	321.65	278.28	208.22	82.25	225.33	250.31
Current Portion of Long-Term Debt	471.34	306.3	370.37	550.64	-	200.17
Current Portion of Leases	-	0.56	0.3	0.28	-	-
Current Income Taxes Payable	164.63	170.55	11.88	21.75	153.51	95.69
Current Unearned Revenue	23.45	29.31	43.95	61.88	53.81	54.6
Other Current Liabilities	367.94	494.84	565.52	782.11	1,407	284.22
Total Current Liabilities	2,554	2,569	2,478	2,465	3,025	1,924
Long-Term Debt	160.09	171.15	230.22	200.19	250.34	500.65
Long-Term Leases	0.12	0.14	0.32	0.62	1.16	-
Long-Term Unearned Revenue	133.51	104.6	84.16	54.11	53.08	34.24
Long-Term Deferred Tax Liabilities	-	-	-	2.47	21.12	11.38
Other Long-Term Liabilities	76.78	82.2	-	-	-	-
Total Liabilities	2,924	2,928	2,793	2,723	3,350	2,470
Common Stock	961.64	961.64	964.98	965.13	965.13	965.13
Additional Paid-In Capital	1,992	1,988	2,005	1,941	1,692	1,398
Retained Earnings	8,281	7,700	6,682	6,417	6,195	5,371
Treasury Stock	-200	-	-27.63	-57.69	-59.98	-59.98
Comprehensive Income & Other	20.4	-1.36	5.77	-5.27	-13.99	0.41
Total Common Equity	11,055	10,648	9,631	9,260	8,779	7,675
Minority Interest	156.23	219.8	355.68	449.98	402.93	355.48
Shareholders' Equity	11,211	10,868	9,986	9,710	9,182	8,030
Total Liabilities & Equity	14,136	13,795	12,780	12,433	12,532	10,500
Total Debt	953.19	756.43	809.44	833.97	476.82	951.12
Net Cash (Debt)	2,234	1,504	978.89	1,051	1,749	998.53
Net Cash Growth	84.02%	53.67%	-6.90%	-39.89%	75.16%	-9.87%
Net Cash Per Share	2.33	1.56	1.03	1.09	1.82	1.04
Filing Date Shares Outstanding	947.91	961.64	902.84	958.3	958.3	958.3
Total Common Shares Outstanding	947.91	961.64	902.84	958.3	958.3	958.3
Working Capital	4,567	4,015	3,123	3,190	3,010	3,194
Book Value Per Share	11.66	11.07	10.67	9.66	9.16	8.01
Tangible Book Value	10,431	9,964	8,868	8,484	8,014	7,265
Tangible Book Value Per Share	11.00	10.36	9.82	8.85	8.36	7.58
Buildings	-	3,032	2,919	2,812	2,509	2,171
Machinery	-	7,418	6,897	6,158	5,366	4,839
Construction In Progress	-	982.5	931.69	825.71	1,119	638.83

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.